Skip to main content
OpenTrials
Completed

NCT Number: NCT03531398

Postprandial Responses to Typical UK Meal Nutrient Profiles

The aim of the current study is to investigate the postprandial metabolic response to typically consumed fat and carbohydrate doses in single meals. An additional aim is to validate the use of dry blood spot (DBS) for triglyceride analysis versus venous blood sampling.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

King's College London

London, UK, SE1 9NH, United Kingdom

About this study

Background: Dietary fat consumption is one of the major modifiable risk factors implicated in the causation of cardiovascular disease (CVD). Postprandial lipaemia (PPL); the increase in circulating blood triacylglycerol (TAG) concentrations after a fat containing meal, is an independent risk factor for cardiovascular disease. However, little is known about how different doses of fats as found in typical UK meals will influence the level of PPL.

The majority of research into PPL, including work by our own group and others has largely focused on the postprandial effect following high fat meals, with the primary goal of assessing mechanisms underlying fat metabolism. However, these findings are not relevant from a public health perspective; in reality the average fat content of a meal is much lower than this (~20- 30 g fat, (NDNS, 2013/4)); therefore it is important to assess the impact of doses of fat in this range on PPL to be relevant to public health. The few dose response studies that have been performed assessing fat load and PPL have used liquid test meals that are not relevant to every day meals.

PPL is usually measured by taking a series of blood samples from a cannula, however this is an invasive procedure. There has been an increase in the development of less invasive biochemical assessment, e.g. urine or saliva analysis or dried blood spot (DBS) analysis. DBS analysis is particularly advantageous as samples can be easily collected by the individual under assessment with minimal equipment and transferred easily for analysis via the post, providing simple home-testing. Frequently, postprandial research studies will draw blood from the cannula for multiple related outcomes and therefore, performing multiple assays from one DBS sample would be advantageous in minimizing participant discomfort.

Aim: The primary aim of the current study is to investigate the postprandial response following typical UK meal nutrient profiles containing 20-30g fat. Secondary aims will be to test the feasibility for measuring PPL, insulin, c-peptide and performing metabolomic analysis from DBS versus serum blood analysis. Further, it will assess the best practice for collection (venous versus finger prick) and storage (ambient versus freezer) of the DBS samples.

Hypothesis: Typical UK meal nutrient profiles will elicit detectable PPL. Further, DBS will be an effective method for measuring postprandial outcomes.

Expected value: The study will provide novel information on the effect of fat doses from typical UK meals on PPL. It will also provide feasibility for using DBS for measuring postprandial responses.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Males and females aged 18-65 years.
  • Free of diagnosed diseases listed in exclusion criteria.
  • Able to understand the information sheet and willing to comply with study protocol.
  • Able to give informed consent.

Exclusion criteria

Refuse or are unable to give informed consent to participate in the study

  • BMI >32 kg/m2
  • BP >170/100 mm Hg
  • Have had long term inflammatory disease or cancer in the last three years.
  • Have had long term gastrointestinal disorders including inflammatory bowel disease (IBD) or Coeliac disease (gluten allergy).
  • Are taking the following daily medications: immunosuppressants, antibiotics in the last three months
  • Are long-term users of PPIs, unless they are able to stop two weeks before the start of the study.
  • Have type I diabetes mellitus or type II diabetes mellitus.
  • Are currently suffering from acute clinically diagnosed depression.
  • Have had a heart attack (myocardial infarction) or stroke in the last 6 months.
  • Are pregnant
  • Are vegan, suffering from an eating disorder or unwilling to take foods that are part of the study.

Treatment and study plan

Metabolic test meal challenge

Other

Metabolic test meal challenge

Primary outcomes

  1. Postprandial lipaemia

    Time frame: 0-4 hours postprandially

    Change in serum triglycerides

Secondary outcomes

  1. Postprandial glycaemia

    Time frame: 0-4 hours postprandially

    Change in plasma glucose

Other outcomes

  1. Postprandial plasma insulin

    Time frame: 0-4 hours postprandially

    Change in plasma insulin

  2. Postprandial plasma c-peptide

    Time frame: 0-4 hours postprandially

    Change in plasma C-peptide

Sponsors and collaborators

Lead sponsor

King's College London

Other

Registry information

Acronym: Pre-PREDICT

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
May 21, 2018
Registry last updated
Feb 18, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.